Related Experiment Video
Updated: Apr 17, 2026

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.8K
Ischaemic postconditioning: cardiac protection after the event.
1School of Medicine and BHF Centre of Excellence, Cardiovascular Division, King's College London, London, UK.
Anaesthesia
|February 17, 2015
Summary
Cardiac ischaemic postconditioning offers cardioprotection by reducing reperfusion injury after heart attacks. However, its clinical benefits require large trials to overcome patient and application variability.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Ischaemic Heart Disease Research
Background:
- Ischaemic heart disease is a leading global cause of death, necessitating novel cardioprotective strategies.
- Cardiac ischaemic postconditioning is a promising technique to mitigate reperfusion injury.
- Existing evidence shows infarct size reduction and improved ejection fraction with postconditioning.
Purpose of the Study:
- To review the development of cardiac ischaemic postconditioning algorithms.
- To highlight findings from current proof-of-concept trials.
- To identify barriers to the clinical adoption of postconditioning.
Main Methods:
- Review of current postconditioning algorithms and proof-of-concept trial data.
- Analysis of factors influencing postconditioning efficacy.
- Discussion of challenges for broad clinical implementation.
Main Results:
- Postconditioning demonstrates potential for reducing reperfusion injury and improving cardiac function.
- Efficacy is highly dependent on patient selection, timing, and endpoints.
- Confounders like age, sex, medication, and comorbidities impact outcomes.
Conclusions:
- Postconditioning's benefits can be attenuated, requiring careful patient selection and timely application.
- Large-scale trials are essential to validate its efficacy and ensure robust clinical applicability.
- Overcoming barriers is crucial for widespread adoption in clinical practice.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K
Acute Coronary Syndrome IV: Interprofessional Care
499
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Exercise and Cardiovascular Response
6.4K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.4K
Ischemic Heart Disease: Overview
4.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K

